T. Rowe Price Associates »

Oncology Institu shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Oncology Institu (TOI) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Oncology Institu

Tip: Access up to 7 years of quarterly data

All positions including Oncology Institu held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncology Institu by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $149k 48k 3.09
2025-12-31 $136k 38k 3.58
2025-09-30 $104k 30k 3.49
2025-06-30 $62k 30k 2.08

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Oncology Institu

BlackRock
Deerfield Management Company
Vanguard Capital Management
Josh Arnold Investment Consultant
Geode Capital Management
Citadel Advisors
Goldman Sachs Group
Wexford Capital
Susquehanna International
State Street Corporation
Nuveen
Renaissance Technologies
Jane Street
CenterBook Partners
Marshall Wace

View all funds holding Oncology Institu